These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26722409)

  • 1. Role of p19ink4d in the pathogenesis of hearing loss.
    Lai R; Li J; Hu P; Wen J; Jie Q; Dong Y; Peng T; Liu X; Xie D
    Int J Clin Exp Pathol; 2015; 8(10):12243-51. PubMed ID: 26722409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of P19ink4d in the pathogenesis and development of hearing loss].
    Lai RS; Li W; Wang T; Li JK; Hu P; Dong YP; Xie DH; Yang XM
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):152-156. PubMed ID: 30808142
    [No Abstract]   [Full Text] [Related]  

  • 3. A mouse model for human deafness DFNB22 reveals that hearing impairment is due to a loss of inner hair cell stimulation.
    Lukashkin AN; Legan PK; Weddell TD; Lukashkina VA; Goodyear RJ; Welstead LJ; Petit C; Russell IJ; Richardson GP
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19351-6. PubMed ID: 23129639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
    Bielefeld EC
    Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring hearing during ototoxic cisplatin therapy].
    Kluba J; Kluba U; von Specht H; Mittler U
    Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue from early-onset hearing loss in a mouse model lacking the cyclin-dependent kinase inhibitor p19Ink4d.
    Ma Q; Grati M; Bai F; Pei J; Pei XH; Liu X
    Cell Death Dis; 2016 Mar; 7(3):e2131. PubMed ID: 26962681
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of thermal treatment via irrigation of external ear to reduce cisplatin-induced hearing loss.
    Spankovich C; Lobarinas E; Ding D; Salvi R; Le Prell CG
    Hear Res; 2016 Feb; 332():55-60. PubMed ID: 26639015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
    Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
    J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxic impact of cisplatin in pediatric oncology patients.
    Berg AL; Spitzer JB; Garvin JH
    Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNAs in inner ear development and hearing loss.
    Mittal R; Liu G; Polineni SP; Bencie N; Yan D; Liu XZ
    Gene; 2019 Feb; 686():49-55. PubMed ID: 30389561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Constitute, imaging and auditory characteristics of pediatric patients with congenital malformations of inner ear in sensorineural hearing loss].
    Li Y; Yang J; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(1):1-5. PubMed ID: 21469382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pneumococcal proteins in sensorineural hearing loss due to otitis media.
    Tsuprun V; Cureoglu S; Schachern PA; Ferrieri P; Briles DE; Paparella MM; Juhn SK
    Otol Neurotol; 2008 Dec; 29(8):1056-60. PubMed ID: 18833010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro mouse model of congenital cytomegalovirus-induced pathogenesis of the inner ear cochlea.
    Melnick M; Jaskoll T
    Birth Defects Res A Clin Mol Teratol; 2013 Feb; 97(2):69-78. PubMed ID: 23281115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss.
    Lee CH; Kim KW; Lee SM; Kim SY
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
    Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
    Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.